Skip to content

“People of the Portal”: Noblegen acquired by U.S.-based Solar Biotech – confirms commitment to future R&D facility at Cleantech Commons

In our “People of the Portal” series, we highlight innovative and entrepreneurial members of the Cleantech Commons Cleantech Innovation Portal and celebrate the achievements of Portal members.

This week, we are delighted to let you know more about a Cleantech Commons Cleantech Innovation Portal client, Noblegen, an advanced digital biology company headquartered in Peterborough, ON. Noblegen was acquired on July 25 by Solar Biotech, a U.S. developer and producer of synthetic biology products headquartered in Norton, Virginia.

Under the terms of the acquisition, Noblegen will now be known as Solar Biotech Canada, with Noblegen’s Canadian operations continuing as the organization’s food-grade-certified (SQF9) biomanufacturing and research & development hub. You can read more about this deal here!

The acquisition is designed to take advantage of the strengths the two companies have in the microbiology and biomanufacturing field to offer revolutionary biotech and synthetic biology-based solutions for a wide range of applications.

Central to the vision of the newly formed SolarBiotech Canada will be the continued development of its “BioNode” facility in Peterborough.

Artist’s impression of Solar Biotech’s proposed BioNode at Cleantech Commons

This will include Noblegen’s current GEN1 facility, with a total capacity of over 160,000 litres of fermentation and extensive bioprocessing equipment, as well as a new GEN2 facility – with over 2 million litres of fermentation capacity and fully integrated downstream and drying for all types of processes and products from micro-organisms such as bacteria, fungi, yeasts, protozoa, algae, viruses, and eukaryotic cell culture.

Solar Biotech has confirmed that it is committed to locating its GEN2 facility at the Cleantech Commons research park, with which it is currently exploring tenancy options.

Adam Noble, CEO and Founder of Noblegen, now Chief Visionary Officer of Solar Biotech Canada.

With this strategic move, we aim to further accelerate our research and development efforts, focusing on groundbreaking innovations that align with Cleantech Commons’ mission of sustainable technology advancement,” says Adam Noble, CEO and founder of Noblegen and newly appointed Chief Visionary Officer of Solar Biotech Canada.

Noble told Arthur that he continues to see “tremendous potential in combining [Solar Biotech Canada’s] expertise with Cleantech Commons, creating opportunities for synergistic growth and impactful advancements in the cleantech space.”

Cleantech Innovation Portal

The Cleantech Commons Cleantech Innovation Portal is all about helping Canadian ventures in the cleantech sector create opportunities for growth, scaling, funding, and commercial success. To learn more or to sign up for free, click here!